Bacterial keratitis in Christchurch, New Zealand, 1997-2001

Clinical and Experimental Ophthalmology

Volumn 32, Issue 5, 2004, Pages 478-481

  Hall, Reece C ^a   McKellar, Malcolm J ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b CHRISTCHURCH HOSPITAL   (New Zealand)

Author keywords

Bacterial keratitis; Corneal scrape; Initial treatment; Monotherapy; Regional variability

Indexed keywords

CHLORAMPHENICOL; CIPROFLOXACIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; BACTERIUM CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COMMUNITY; CONTROLLED STUDY; CORYNEBACTERIUM; GEOGRAPHIC DISTRIBUTION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GRAM STAINING; HOSPITAL DEPARTMENT; HUMAN; INCIDENCE; KERATITIS; MAJOR CLINICAL STUDY; MICROBIOLOGICAL EXAMINATION; MORAXELLA; NEW ZEALAND; NONHUMAN; OPHTHALMOLOGY; PATIENT CARE; PSEUDOMONAS AERUGINOSA; REVIEW;

ANTI-INFECTIVE AGENTS; BACTERIA; BACTERIAL TYPING TECHNIQUES; CORNEA; CORNEAL ULCER; DRUG RESISTANCE, BACTERIAL; EYE INFECTIONS, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NEW ZEALAND;

EID: 8644249889     PISSN: 14426404     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2004.00867.x     Document Type: Review

References (15)

1. Tuft SJ, Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol 2000; 84: 687-91.
2. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999; 106: 1313-18.
3. Kunimoto DY, Sharma S, Garg P, Rao GN. In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin. Ophthalmology 1999; 106: 80-85.
4. Doona M, Walsh JB. Use of chloramphenicol as topical eye medication: time to cry halt? BMJ 1995; 310: 1217-18.
5. McGhee CNJ, Anastas CN. Widespread ocular use of topical chloramphenicol: is there justifiable concern regarding idiosyncratic aplastic anaemia? Br J Ophthalmol 1996; 80: 182-4.
6. The Ofloxacin Study Group. Ofloxacin montherapy for the primary treatment of microbial keratitis. Ophthalmology 1997; 104: 1902-9.
7. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107: 1497-502.
8. Garg P, Sharma S, Rao GN. Ciprofloxacin-resistant Pseudomonas keratitis. Ophthalmology 1999; 106: 1319-23.
9. Snyder ME, Katz HR. Ciprofloxacin-resistant bacterial keratitis. Am J Ophthalmol 1992; 114: 336-8.
10. Sharma S, Kunimoto DY, Gopinathan U et al. Evaluation of corneal scraping examination methods in the diagnosis of bacterial and fungal keratitis: a survey of eight years of laboratory experience. Cornea 2002; 21: 643-7.
11. Kaye SB, Rao PG, Smith G et al. Simplifying collection of corneal specimens in cases of suspected bacterial keratitis. J Clin Microbiol 2003; 41: 3192-7.
12. Cockerill FR 3rd. Application of rapid-cycle real-time polymerase chain reaction for diagnostic testing in the clinical microbiology laboratory. Arch Pathol Lab Med 2003; 127: 1112-20.
13. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001; 85: 842-7.
14. Wong T, Ormonde S, Gamble G, McGhee CN. Severe infective keratitis leading to hospital admission in New Zealand. Br J Ophthalmol 2003; 87: 1103-8.
15. McAllum PJ, McGhee CN. Prescribing trends in infectious keratitis: a survey of New Zealand ophthalmologists. Clin Experiment Ophthalmol 2003; 31: 496-504.